Their complementary solvent properties help disrupt the sample and distribute its constituents. Methanol weakens protein and cellular interactions, making biomolecules more accessible, while chloroform preferentially dissolves hydrophobic compounds such as lipids. This division allows membrane-associated and other nonpolar molecules to be recovered separately from more polar components for downstream biochemical analysis.
Water promotes formation of distinct phases within the solvent mixture. As the system separates, hydrophobic lipids become enriched in the organic chloroform-containing layer, whereas polar metabolites, salts, and many proteins are directed toward the aqueous or interfacial fractions. This physical partitioning provides a basis for organizing complex brain extracts before analytical measurements.
A biomolecule’s interaction with the solvents helps determine its distribution among the organic, aqueous, and interfacial fractions. Hydrophobic substances favor the organic layer, while polar metabolites and salts favor the aqueous portion; proteins may occur in aqueous or interfacial material. Interpreting these fractions therefore helps relate an observed signal to the chemical character of the analyte.
A basic workflow begins by treating the biological sample with methanol to disrupt cellular and protein associations, followed by chloroform to solubilize hydrophobic constituents. Water is then added to promote phase separation. The resulting organic, aqueous, and interfacial fractions can be collected as appropriate and examined separately to compare lipid-rich and polar biochemical content.
The system is useful when investigators need to examine chemically diverse constituents in neural tissue rather than measure an undifferentiated sample. In brain studies, it can support characterization of membrane lipids, myelin components, signaling molecules, and metabolic changes. Comparing extracts from different samples may help reveal biochemical alterations associated with neurological disease or other experimental conditions.
Chromatography and mass spectrometry can characterize the molecular composition of the separated extracts. Analysis of the organic fraction can emphasize lipid-related constituents, while aqueous or interfacial material can provide information about polar metabolites, salts, or proteins. These measurements help investigators compare brain composition and identify biochemical changes across neural samples or disease-related conditions.